Rumination-Focused Cognitive Behavioral Therapy Decreases Anxiety and Increases Behavioral Activation Among Remitted Adolescents.
Saved in:
| Title: | Rumination-Focused Cognitive Behavioral Therapy Decreases Anxiety and Increases Behavioral Activation Among Remitted Adolescents. |
|---|---|
| Authors: | Feldhaus, Claudia G. (AUTHOR), Jacobs, Rachel H. (AUTHOR), Watkins, Edward R. (AUTHOR), Peters, Amy T. (AUTHOR), Bessette, Katie L. (AUTHOR), Langenecker, Scott A. (AUTHOR) |
| Source: | Journal of Child & Family Studies. Jul2020, Vol. 29 Issue 7, p1982-1991. 10p. 1 Diagram, 2 Charts, 3 Graphs. |
| Subjects: | Anxiety treatment, Behavior therapy, Mental depression, Classification of mental disorders, Adolescence |
| Abstract: | Rumination involves a repetitive, passive focus on one's thoughts and feelings and has been hypothesized as a mechanism contributing to multiple psychopathologies. The current investigation explores secondary outcomes from a pilot study to examine whether rumination-focused cognitive behavior therapy (RFCBT) alleviates symptoms of anxiety, increases behavioral activation, or increases global functioning among adolescents with a history of Major Depressive Disorder (MDD). Thirty-three adolescents were randomized to receive either RFCBT (n = 17) or assessment only (AO; n = 16) over the course of eight weeks. Mixed effects regression models were used to conduct intent-to-treat (ITT) analyses. The quadratic interaction for group-by-time-by-time was significant for anxiety. Adolescents in the RFCBT group experienced a significant decrease in anxiety across the first six weeks of intervention (F = 7.01, df = 108.49, p = 0.009). The group-by-time interaction was significant for the behavioral activation outcome (F = 4.28, df = 25.60, p = 0.049) with youth randomized to RFCBT demonstrating increasing activation compared to AO. Global functioning did not significantly differ between groups (F = 0.40, df = 1, p > 0.05). Preliminary evidence suggests that RFCBT may hold promise as an intervention that alleviates both depressive and anxiety symptoms when comorbid. Highlights: RFCBT reduces anxiety symptoms among adolescents in remission from depression. SRumination may be a mechanism in both depressive and anxious disorders. Behavioral activation increases among youth randomized to RFCBT. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Child & Family Studies is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Rumination involves a repetitive, passive focus on one's thoughts and feelings and has been hypothesized as a mechanism contributing to multiple psychopathologies. The current investigation explores secondary outcomes from a pilot study to examine whether rumination-focused cognitive behavior therapy (RFCBT) alleviates symptoms of anxiety, increases behavioral activation, or increases global functioning among adolescents with a history of Major Depressive Disorder (MDD). Thirty-three adolescents were randomized to receive either RFCBT (n = 17) or assessment only (AO; n = 16) over the course of eight weeks. Mixed effects regression models were used to conduct intent-to-treat (ITT) analyses. The quadratic interaction for group-by-time-by-time was significant for anxiety. Adolescents in the RFCBT group experienced a significant decrease in anxiety across the first six weeks of intervention (F = 7.01, df = 108.49, p = 0.009). The group-by-time interaction was significant for the behavioral activation outcome (F = 4.28, df = 25.60, p = 0.049) with youth randomized to RFCBT demonstrating increasing activation compared to AO. Global functioning did not significantly differ between groups (F = 0.40, df = 1, p > 0.05). Preliminary evidence suggests that RFCBT may hold promise as an intervention that alleviates both depressive and anxiety symptoms when comorbid. Highlights: RFCBT reduces anxiety symptoms among adolescents in remission from depression. SRumination may be a mechanism in both depressive and anxious disorders. Behavioral activation increases among youth randomized to RFCBT. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10621024 |
| DOI: | 10.1007/s10826-020-01711-7 |
